More and more blood tests to screen for cancer are coming on the market, with a new one looking at proteins in the blood helping identify who is at risk to develop lung cancer. Kimmel Cancer Center director William Nelson …

How often can a blood test predict cancer risk? Elizabeth Tracey reports Read more →

When someone has a years-long, multiple pack history of smoking, they are recommended to undergo screening for lung cancer utilizing a technology known as low dose computed tomography or low dose CT. Yet only about 18% of those eligible for …

Will a blood test compel more people to be screened for lung cancer? Elizabeth Tracey reports Read more →

People with a history of tobacco smoking are recommended to have screening CT for lung cancer, but many of them choose not to be screened. A new study looks at the ability of a blood test to discern who is …

Can a blood test improve lung cancer screening? Elizabeth Tracey reports Read more →

A blood test used for population based cancer screening fell short of allowing cancers to be detected earlier, was cost prohibitive and delayed diagnoses for others, a new study shows. Johns Hopkins Kimmel Cancer Center director William Nelson says both …

What do false positives and negatives have to do with screening tests for cancer? Elizabeth Tracey reports Read more →

A blood test capable of detecting multiple cancers seems like a dream come true, yet a new study looking at such a test used in populations of people failed to find cancers earlier, and also delayed diagnosis for others. William …

Just how expensive could it be to screen populations of people for cancer using blood tests? Elizabeth Tracey reports Read more →

When large populations of people were screened for multiple cancers using a blood test, not only didn’t cancers get found earlier, others who were not screened had delays in their diagnosis and treatment of cancer. Johns Hopkins Kimmel Cancer Center …

Should blood tests to screen for cancer be used on a population basis? Elizabeth Tracey reports Read more →

For some types of cancer obesity is clearly a risk factor. Now a new study shows that when people with obesity take a GLP-1 agonist to lose weight, they also reduce their risk for these cancers. Kimmel Cancer Center director …

How do GLP-1 agonists compare against other strategies for weight reduction and cancer risk reduction? Elizabeth Tracey reports Read more →

GLP-1 agonists are a class of drugs originally developed to treat diabetes but have been shown to be helpful for weight loss. Now a new study looks at whether their use reduces the risk of obesity related cancers. William Nelson, …

How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports Read more →

Making CAR-T cells from donor bone marrow already used to treat someone’s cancer helped rein in cancer recurrence, a new study shows. Kimmel Cancer Center director William Nelson at Johns Hopkins says this is one more place where an expansion …

Can a new method for developing CAR-T cells to treat cancer be expanded? Elizabeth Tracey reports Read more →

CAR-T cells developed from bone marrow donors whose bone marrow had already been used to treat someone’s cancer may be able to rein in cancer recurrence, a new study finds. Johns Hopkins Kimmel Cancer Center director William Nelson says this …

Can donor CAR-T cells have an impact on cancer treatment? Elizabeth Tracey reports Read more →